Christine Dolan - 15 May 2025 Form 4 Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Role
Executive Vice President & General Manager, Cygnus Technologies
Signature
/s/ Kurt Oreshack, by power of attorney for Christine Dolan
Issuer symbol
MRVI
Transactions as of
15 May 2025
Net transactions value
+$3,976
Form type
4
Filing time
28 May 2025, 17:51:30 UTC
Previous filing
19 Mar 2025
Next filing
18 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dolan Christine Executive Vice President & General Manager, Cygnus Technologies C/O MARAVAI LIFESCIENCES HOLDINGS, INC., 10770 WATERIDGE CIRCLE, SUITE 200, SAN DIEGO /s/ Kurt Oreshack, by power of attorney for Christine Dolan 28 May 2025 0001684273

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVI Class A Common Stock Award $3,976 +2,381 +0.51% $1.67 473,607 15 May 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 2,381 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

Remarks:

Executive Vice President & General Manager, Cygnus Technologies